The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Mundinger Mary Oneil since year 2005.
The trader's CIK number is 1179980.
At the time of this reporting, Mundinger Mary Oneil is the Director of Cell Therapeutics Inc .
(stock ticker symbol CTIC).
See this page for all insider trading activities at Cell Therapeutics Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2013-08-07||CTIC||Cell Therapeutics Inc||Sale||125,000||1.06||133,125|
|2013-03-08||CTIC||Cell Therapeutics Inc||Sale||37,500||1.28||48,187|
|2013-03-07||CTIC||Cell Therapeutics Inc||Sale||37,500||1.27||47,737|
|2009-05-14||GTIV||Gentiva Health Services Inc||Option Ex||12,444||.00||0|
|2007-12-11||UNH||Unitedhealth Group Inc||Sale||32,000||58.00||1,856,000|
|2007-12-11||UNH||Unitedhealth Group Inc||Option Ex||32,000||9.09||290,976|
|2007-04-20||UNH||Unitedhealth Group Inc||Sale||12,000||52.61||631,296|
|2007-04-20||UNH||Unitedhealth Group Inc||Option Ex||12,000||6.45||77,436|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mundinger Mary Oneil (Director of Cell Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.